| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress Disorders, Post-Traumatic | 137 | 2024 | 4547 | 6.630 |
Why?
|
| Combat Disorders | 46 | 2024 | 301 | 5.520 |
Why?
|
| Propranolol | 18 | 2022 | 489 | 4.970 |
Why?
|
| Veterans | 48 | 2024 | 2640 | 2.280 |
Why?
|
| Imagination | 20 | 2017 | 226 | 2.060 |
Why?
|
| Galvanic Skin Response | 45 | 2017 | 348 | 1.930 |
Why?
|
| Extinction, Psychological | 17 | 2016 | 371 | 1.810 |
Why?
|
| Fear | 31 | 2016 | 1462 | 1.710 |
Why?
|
| Adrenergic beta-Antagonists | 11 | 2022 | 1256 | 1.640 |
Why?
|
| Amygdala | 23 | 2024 | 1350 | 1.640 |
Why?
|
| Mental Recall | 23 | 2022 | 1205 | 1.610 |
Why?
|
| Child Abuse, Sexual | 14 | 2002 | 393 | 1.540 |
Why?
|
| Conditioning, Classical | 17 | 2016 | 364 | 1.420 |
Why?
|
| Arousal | 26 | 2014 | 1157 | 1.350 |
Why?
|
| Memory | 18 | 2020 | 2179 | 1.210 |
Why?
|
| Vietnam Conflict | 9 | 2015 | 100 | 1.180 |
Why?
|
| Stress, Psychological | 17 | 2024 | 4440 | 1.170 |
Why?
|
| Diseases in Twins | 8 | 2011 | 447 | 1.110 |
Why?
|
| Heart Rate | 39 | 2024 | 4169 | 1.000 |
Why?
|
| Vietnam | 27 | 2007 | 411 | 0.900 |
Why?
|
| Gyrus Cinguli | 10 | 2012 | 1113 | 0.840 |
Why?
|
| Prefrontal Cortex | 12 | 2017 | 2212 | 0.820 |
Why?
|
| Mifepristone | 2 | 2014 | 150 | 0.800 |
Why?
|
| Tomography, Emission-Computed | 11 | 2004 | 1121 | 0.780 |
Why?
|
| Repression, Psychology | 5 | 2002 | 45 | 0.770 |
Why?
|
| Implosive Therapy | 3 | 2018 | 124 | 0.750 |
Why?
|
| Twins, Monozygotic | 14 | 2024 | 469 | 0.720 |
Why?
|
| Twins | 3 | 2008 | 339 | 0.720 |
Why?
|
| Life Change Events | 19 | 2014 | 953 | 0.710 |
Why?
|
| Acoustic Stimulation | 12 | 2013 | 1232 | 0.640 |
Why?
|
| Hippocampus | 14 | 2012 | 3737 | 0.590 |
Why?
|
| Psychophysiology | 10 | 2014 | 136 | 0.520 |
Why?
|
| Electromyography | 24 | 2017 | 1386 | 0.510 |
Why?
|
| Psychomotor Performance | 8 | 2013 | 1876 | 0.510 |
Why?
|
| Emotions | 20 | 2022 | 2730 | 0.480 |
Why?
|
| Psychiatric Status Rating Scales | 25 | 2017 | 6017 | 0.460 |
Why?
|
| Postpartum Period | 3 | 2022 | 1168 | 0.460 |
Why?
|
| Adult | 138 | 2024 | 219847 | 0.460 |
Why?
|
| Wounds and Injuries | 8 | 2010 | 2477 | 0.460 |
Why?
|
| Delivery, Obstetric | 3 | 2022 | 933 | 0.450 |
Why?
|
| Male | 167 | 2024 | 359413 | 0.450 |
Why?
|
| Pattern Recognition, Visual | 3 | 2011 | 810 | 0.440 |
Why?
|
| Middle Aged | 110 | 2024 | 220175 | 0.430 |
Why?
|
| Desensitization, Psychologic | 3 | 2000 | 27 | 0.420 |
Why?
|
| Perceptual Disorders | 1 | 2015 | 197 | 0.420 |
Why?
|
| Humans | 230 | 2024 | 760261 | 0.420 |
Why?
|
| Fluorodeoxyglucose F18 | 11 | 2023 | 2007 | 0.420 |
Why?
|
| Military Personnel | 5 | 2020 | 1245 | 0.420 |
Why?
|
| Hydrocortisone | 10 | 2013 | 1798 | 0.410 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2014 | 400 | 0.410 |
Why?
|
| Reward | 3 | 2009 | 964 | 0.410 |
Why?
|
| Post-Concussion Syndrome | 1 | 2015 | 238 | 0.400 |
Why?
|
| Image Processing, Computer-Assisted | 11 | 2011 | 8945 | 0.390 |
Why?
|
| Habituation, Psychophysiologic | 9 | 2014 | 147 | 0.390 |
Why?
|
| Brain Injuries | 3 | 2015 | 2044 | 0.380 |
Why?
|
| Hormone Antagonists | 1 | 2011 | 108 | 0.380 |
Why?
|
| Drive | 1 | 2011 | 34 | 0.380 |
Why?
|
| Dementia | 2 | 2017 | 2638 | 0.370 |
Why?
|
| Attention | 6 | 2011 | 2386 | 0.360 |
Why?
|
| Cues | 4 | 2014 | 867 | 0.360 |
Why?
|
| Obsessive-Compulsive Disorder | 9 | 2007 | 1488 | 0.360 |
Why?
|
| Magnetic Resonance Imaging | 27 | 2017 | 36247 | 0.350 |
Why?
|
| Noise, Transportation | 2 | 2021 | 51 | 0.350 |
Why?
|
| Gambling | 2 | 2013 | 258 | 0.350 |
Why?
|
| Sleep | 4 | 2017 | 4746 | 0.340 |
Why?
|
| Problem Solving | 2 | 2011 | 440 | 0.340 |
Why?
|
| Female | 121 | 2024 | 391011 | 0.330 |
Why?
|
| Generalization, Stimulus | 1 | 2009 | 13 | 0.330 |
Why?
|
| Survivors | 7 | 2007 | 2367 | 0.330 |
Why?
|
| Dissociative Disorders | 4 | 2012 | 233 | 0.310 |
Why?
|
| Brain Concussion | 1 | 2020 | 1394 | 0.310 |
Why?
|
| Facial Expression | 4 | 2022 | 509 | 0.310 |
Why?
|
| Psychometrics | 17 | 2015 | 3049 | 0.300 |
Why?
|
| Analysis of Variance | 17 | 2015 | 6242 | 0.300 |
Why?
|
| Brain | 18 | 2024 | 26912 | 0.300 |
Why?
|
| Septum Pellucidum | 2 | 2006 | 54 | 0.300 |
Why?
|
| Depression | 6 | 2024 | 8033 | 0.290 |
Why?
|
| Military Nursing | 2 | 2008 | 8 | 0.290 |
Why?
|
| Behavior, Addictive | 1 | 2013 | 462 | 0.290 |
Why?
|
| Neurologic Examination | 4 | 2006 | 916 | 0.290 |
Why?
|
| Eye Movements | 3 | 2000 | 508 | 0.290 |
Why?
|
| Panic Disorder | 4 | 2008 | 613 | 0.280 |
Why?
|
| Brain Mapping | 11 | 2011 | 6562 | 0.280 |
Why?
|
| Interview, Psychological | 3 | 2006 | 812 | 0.280 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2013 | 917 | 0.280 |
Why?
|
| Cardiovascular Diseases | 7 | 2024 | 15740 | 0.280 |
Why?
|
| Evoked Potentials, Auditory | 4 | 2008 | 529 | 0.280 |
Why?
|
| Visual Perception | 3 | 2008 | 1374 | 0.280 |
Why?
|
| Neuropsychological Tests | 15 | 2015 | 7016 | 0.280 |
Why?
|
| Aggression | 4 | 2003 | 745 | 0.270 |
Why?
|
| Crime Victims | 2 | 2017 | 329 | 0.270 |
Why?
|
| Cerebrovascular Circulation | 7 | 2011 | 2731 | 0.270 |
Why?
|
| Violence | 4 | 2017 | 927 | 0.260 |
Why?
|
| Adaptation, Psychological | 7 | 2014 | 2628 | 0.260 |
Why?
|
| Rest | 2 | 2012 | 915 | 0.260 |
Why?
|
| Blinking | 7 | 2007 | 133 | 0.250 |
Why?
|
| Beauty | 1 | 2005 | 41 | 0.250 |
Why?
|
| Adrenergic Antagonists | 1 | 2005 | 26 | 0.250 |
Why?
|
| Rhinoplasty | 1 | 2009 | 238 | 0.250 |
Why?
|
| Intra-Abdominal Fat | 2 | 2021 | 607 | 0.240 |
Why?
|
| Comorbidity | 15 | 2020 | 10552 | 0.240 |
Why?
|
| Cognition | 4 | 2020 | 6948 | 0.240 |
Why?
|
| Cocaine-Related Disorders | 1 | 2008 | 460 | 0.230 |
Why?
|
| Recovery of Function | 1 | 2015 | 2982 | 0.230 |
Why?
|
| Disability Evaluation | 2 | 2012 | 1826 | 0.230 |
Why?
|
| Documentation | 1 | 2010 | 892 | 0.230 |
Why?
|
| Regional Blood Flow | 6 | 2009 | 1490 | 0.230 |
Why?
|
| Cerebellum | 2 | 2013 | 1495 | 0.230 |
Why?
|
| Defibrillators, Implantable | 1 | 2014 | 1499 | 0.230 |
Why?
|
| Depressive Disorder | 6 | 2003 | 3728 | 0.230 |
Why?
|
| Personality Assessment | 3 | 2000 | 650 | 0.220 |
Why?
|
| Functional Laterality | 8 | 2015 | 2253 | 0.210 |
Why?
|
| Widowhood | 1 | 2003 | 51 | 0.210 |
Why?
|
| Perceptual Distortion | 1 | 2002 | 36 | 0.210 |
Why?
|
| Rape | 3 | 2017 | 130 | 0.210 |
Why?
|
| Somatoform Disorders | 2 | 2003 | 423 | 0.210 |
Why?
|
| Nervous System Diseases | 2 | 2006 | 1647 | 0.210 |
Why?
|
| Memory Disorders | 3 | 2009 | 1197 | 0.210 |
Why?
|
| Positron-Emission Tomography | 5 | 2024 | 6457 | 0.210 |
Why?
|
| Cognition Disorders | 2 | 2015 | 3976 | 0.210 |
Why?
|
| Double-Blind Method | 10 | 2018 | 12412 | 0.200 |
Why?
|
| Memory, Long-Term | 2 | 2013 | 58 | 0.200 |
Why?
|
| Anxiety | 2 | 2024 | 4532 | 0.200 |
Why?
|
| Refugees | 2 | 2008 | 598 | 0.190 |
Why?
|
| Face | 2 | 2005 | 1017 | 0.190 |
Why?
|
| Autonomic Nervous System | 2 | 2013 | 697 | 0.190 |
Why?
|
| Fantasy | 2 | 2000 | 69 | 0.190 |
Why?
|
| Risk Factors | 28 | 2024 | 74269 | 0.190 |
Why?
|
| Orientation | 1 | 2002 | 321 | 0.190 |
Why?
|
| Anxiety Disorders | 9 | 2012 | 2711 | 0.180 |
Why?
|
| Nerve Net | 3 | 2009 | 2258 | 0.180 |
Why?
|
| Avoidance Learning | 2 | 2000 | 248 | 0.180 |
Why?
|
| Young Adult | 20 | 2020 | 58673 | 0.180 |
Why?
|
| Schizophrenic Psychology | 6 | 2015 | 1646 | 0.170 |
Why?
|
| Homicide | 1 | 2003 | 295 | 0.170 |
Why?
|
| Endorphins | 2 | 1990 | 74 | 0.170 |
Why?
|
| Libido | 2 | 1999 | 119 | 0.170 |
Why?
|
| Hallucinations | 1 | 2002 | 366 | 0.170 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2021 | 124 | 0.160 |
Why?
|
| Chronic Disease | 9 | 2020 | 9283 | 0.160 |
Why?
|
| Case-Control Studies | 14 | 2018 | 22041 | 0.160 |
Why?
|
| Israel | 6 | 2000 | 722 | 0.160 |
Why?
|
| Nurses | 4 | 2007 | 2468 | 0.160 |
Why?
|
| Adolescent | 28 | 2020 | 87747 | 0.160 |
Why?
|
| Electroencephalography | 7 | 2008 | 6182 | 0.160 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 1998 | 93 | 0.160 |
Why?
|
| Hematopoietic System | 1 | 2018 | 109 | 0.160 |
Why?
|
| Pilot Projects | 5 | 2015 | 8553 | 0.150 |
Why?
|
| Severity of Illness Index | 13 | 2012 | 15827 | 0.150 |
Why?
|
| Association Learning | 3 | 2010 | 219 | 0.150 |
Why?
|
| Hospitalization | 3 | 2017 | 10761 | 0.150 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2012 | 1067 | 0.150 |
Why?
|
| Bone Marrow | 2 | 2019 | 2918 | 0.150 |
Why?
|
| Circadian Rhythm | 4 | 2014 | 2567 | 0.150 |
Why?
|
| Cerebral Cortex | 9 | 2013 | 5755 | 0.140 |
Why?
|
| Longitudinal Studies | 10 | 2020 | 14482 | 0.140 |
Why?
|
| Arteritis | 1 | 2019 | 162 | 0.140 |
Why?
|
| Premedication | 1 | 2018 | 253 | 0.140 |
Why?
|
| Facial Muscles | 4 | 2013 | 159 | 0.130 |
Why?
|
| Radiopharmaceuticals | 4 | 2023 | 2633 | 0.130 |
Why?
|
| Dreams | 1 | 2017 | 146 | 0.130 |
Why?
|
| Death | 1 | 2000 | 678 | 0.130 |
Why?
|
| Obesity, Abdominal | 1 | 2019 | 375 | 0.130 |
Why?
|
| Child | 24 | 2009 | 79758 | 0.130 |
Why?
|
| Depersonalization | 2 | 2012 | 39 | 0.120 |
Why?
|
| Reaction Time | 4 | 2011 | 2075 | 0.120 |
Why?
|
| Neurobiology | 2 | 2021 | 137 | 0.120 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2014 | 296 | 0.120 |
Why?
|
| Venous Thrombosis | 1 | 2024 | 1293 | 0.120 |
Why?
|
| Aged | 25 | 2024 | 168995 | 0.120 |
Why?
|
| Wakefulness | 2 | 2014 | 1253 | 0.120 |
Why?
|
| Personality Development | 2 | 1993 | 244 | 0.120 |
Why?
|
| Tourette Syndrome | 3 | 1988 | 394 | 0.120 |
Why?
|
| Limbic System | 5 | 1999 | 419 | 0.120 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2017 | 269 | 0.120 |
Why?
|
| Mental Status Schedule | 1 | 2015 | 314 | 0.120 |
Why?
|
| Environment | 1 | 2020 | 1118 | 0.120 |
Why?
|
| Regression Analysis | 5 | 2017 | 6361 | 0.120 |
Why?
|
| Personality Inventory | 5 | 2008 | 1018 | 0.110 |
Why?
|
| Attitude to Health | 1 | 2003 | 2028 | 0.110 |
Why?
|
| Nervous System | 1 | 1997 | 543 | 0.110 |
Why?
|
| Accidents, Traffic | 5 | 2007 | 814 | 0.110 |
Why?
|
| Arginine Vasopressin | 1 | 1993 | 125 | 0.110 |
Why?
|
| Insanity Defense | 1 | 1993 | 28 | 0.110 |
Why?
|
| Actigraphy | 1 | 2017 | 518 | 0.110 |
Why?
|
| Intelligence | 1 | 1998 | 919 | 0.110 |
Why?
|
| Afghan Campaign 2001- | 2 | 2013 | 296 | 0.110 |
Why?
|
| Verbal Behavior | 2 | 1999 | 335 | 0.110 |
Why?
|
| Electroshock | 2 | 2011 | 121 | 0.110 |
Why?
|
| Cardiovascular System | 1 | 2020 | 850 | 0.110 |
Why?
|
| Neural Pathways | 4 | 2024 | 3039 | 0.100 |
Why?
|
| Diagnosis, Differential | 9 | 2010 | 12968 | 0.100 |
Why?
|
| Time Factors | 10 | 2020 | 40133 | 0.100 |
Why?
|
| Alcoholism | 4 | 2002 | 1961 | 0.100 |
Why?
|
| Drug Administration Schedule | 3 | 2007 | 4900 | 0.100 |
Why?
|
| Social Adjustment | 2 | 1993 | 632 | 0.100 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2002 | 3695 | 0.100 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 4 | 2007 | 1988 | 0.100 |
Why?
|
| Demography | 2 | 2015 | 1650 | 0.100 |
Why?
|
| Adiposity | 2 | 2019 | 1851 | 0.100 |
Why?
|
| Arteries | 1 | 2017 | 1126 | 0.100 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2011 | 41 | 0.100 |
Why?
|
| Clonidine | 1 | 2012 | 170 | 0.100 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2012 | 91 | 0.100 |
Why?
|
| Reference Values | 6 | 2010 | 4920 | 0.100 |
Why?
|
| Veterans Health | 1 | 2013 | 216 | 0.100 |
Why?
|
| Retrospective Studies | 14 | 2024 | 80301 | 0.100 |
Why?
|
| Follow-Up Studies | 9 | 2019 | 39254 | 0.090 |
Why?
|
| Statistics as Topic | 2 | 2015 | 2363 | 0.090 |
Why?
|
| Cross-Cultural Comparison | 2 | 2006 | 632 | 0.090 |
Why?
|
| Hematopoiesis | 2 | 2019 | 2063 | 0.090 |
Why?
|
| Word Association Tests | 2 | 2002 | 52 | 0.090 |
Why?
|
| Disease Susceptibility | 2 | 2009 | 1791 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2001 | 3764 | 0.090 |
Why?
|
| Anti-Anxiety Agents | 1 | 2013 | 397 | 0.090 |
Why?
|
| Psoriasis | 1 | 2018 | 939 | 0.090 |
Why?
|
| Cesarean Section | 1 | 2019 | 1386 | 0.090 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2007 | 619 | 0.090 |
Why?
|
| Social Class | 1 | 2019 | 2005 | 0.090 |
Why?
|
| Perception | 1 | 2017 | 1194 | 0.090 |
Why?
|
| Developing Countries | 1 | 2003 | 2880 | 0.090 |
Why?
|
| Expert Testimony | 1 | 1993 | 361 | 0.090 |
Why?
|
| Police | 1 | 2012 | 157 | 0.090 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2009 | 761 | 0.090 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2012 | 415 | 0.090 |
Why?
|
| Association | 1 | 1990 | 52 | 0.090 |
Why?
|
| Trauma Severity Indices | 4 | 2007 | 477 | 0.090 |
Why?
|
| Achievement | 1 | 1991 | 289 | 0.090 |
Why?
|
| New Hampshire | 3 | 2007 | 173 | 0.090 |
Why?
|
| Self Mutilation | 1 | 1990 | 58 | 0.090 |
Why?
|
| Psychological Tests | 3 | 2000 | 639 | 0.080 |
Why?
|
| Cambodia | 2 | 2008 | 186 | 0.080 |
Why?
|
| United States | 13 | 2018 | 72363 | 0.080 |
Why?
|
| Psychotherapy | 1 | 2018 | 1640 | 0.080 |
Why?
|
| Oxytocin | 1 | 1993 | 401 | 0.080 |
Why?
|
| Schizophrenia, Paranoid | 2 | 1987 | 102 | 0.080 |
Why?
|
| Learning | 2 | 2013 | 1733 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2023 | 2880 | 0.080 |
Why?
|
| Registries | 2 | 2004 | 8449 | 0.080 |
Why?
|
| Catecholamines | 1 | 1990 | 385 | 0.080 |
Why?
|
| Tobacco Use Disorder | 1 | 2014 | 700 | 0.080 |
Why?
|
| Animals | 18 | 2020 | 167940 | 0.080 |
Why?
|
| Mental Disorders | 3 | 2019 | 6797 | 0.080 |
Why?
|
| Rats | 6 | 2013 | 23695 | 0.080 |
Why?
|
| Incidence | 6 | 2024 | 21378 | 0.080 |
Why?
|
| Cybernetics | 1 | 1987 | 7 | 0.070 |
Why?
|
| Vasopressins | 1 | 1989 | 355 | 0.070 |
Why?
|
| Child, Preschool | 11 | 2009 | 42034 | 0.070 |
Why?
|
| Anger | 3 | 1999 | 401 | 0.070 |
Why?
|
| Parturition | 2 | 2022 | 445 | 0.070 |
Why?
|
| Naloxone | 1 | 1990 | 369 | 0.070 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 7803 | 0.070 |
Why?
|
| Tuberculosis | 3 | 2009 | 2003 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2014 | 1297 | 0.070 |
Why?
|
| Blood Pressure | 3 | 1998 | 8523 | 0.070 |
Why?
|
| Frontal Lobe | 3 | 2000 | 1422 | 0.070 |
Why?
|
| Expressed Emotion | 1 | 2007 | 92 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2013 | 10829 | 0.070 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 25928 | 0.070 |
Why?
|
| Pituitary-Adrenal System | 2 | 2007 | 550 | 0.070 |
Why?
|
| Motor Vehicles | 1 | 2008 | 281 | 0.070 |
Why?
|
| Thinking | 1 | 1990 | 319 | 0.070 |
Why?
|
| Oxygen | 5 | 2009 | 4189 | 0.070 |
Why?
|
| Synaptic Transmission | 1 | 2013 | 1169 | 0.070 |
Why?
|
| Molecular Epidemiology | 1 | 2009 | 469 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2013 | 8157 | 0.070 |
Why?
|
| American Civil War | 1 | 2006 | 8 | 0.070 |
Why?
|
| Hysteria | 2 | 1987 | 20 | 0.070 |
Why?
|
| Saliva | 4 | 2013 | 816 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2019 | 2809 | 0.070 |
Why?
|
| Dominance, Cerebral | 1 | 2007 | 622 | 0.070 |
Why?
|
| Corpus Striatum | 1 | 2012 | 1233 | 0.070 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2007 | 698 | 0.070 |
Why?
|
| Object Attachment | 3 | 1993 | 324 | 0.070 |
Why?
|
| Progesterone | 1 | 2010 | 742 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 12281 | 0.060 |
Why?
|
| Analgesia | 1 | 1990 | 459 | 0.060 |
Why?
|
| Dominance-Subordination | 2 | 1975 | 26 | 0.060 |
Why?
|
| Probability | 2 | 2003 | 2476 | 0.060 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2006 | 105 | 0.060 |
Why?
|
| Inpatients | 1 | 2017 | 2578 | 0.060 |
Why?
|
| Social Dominance | 2 | 1975 | 39 | 0.060 |
Why?
|
| Dizziness | 1 | 2008 | 256 | 0.060 |
Why?
|
| Fires | 1 | 2006 | 169 | 0.060 |
Why?
|
| Oxygen Consumption | 1 | 2011 | 1840 | 0.060 |
Why?
|
| Translating | 1 | 2006 | 148 | 0.060 |
Why?
|
| Education | 1 | 2008 | 535 | 0.060 |
Why?
|
| Psychophysics | 3 | 2013 | 289 | 0.060 |
Why?
|
| Psychoanalytic Theory | 2 | 1975 | 138 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2008 | 18134 | 0.060 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2005 | 178 | 0.060 |
Why?
|
| Epinephrine | 1 | 2007 | 791 | 0.060 |
Why?
|
| Blood Platelets | 1 | 1995 | 2522 | 0.060 |
Why?
|
| Culture | 1 | 2008 | 622 | 0.060 |
Why?
|
| Body Image | 1 | 2009 | 634 | 0.060 |
Why?
|
| Vehicle Emissions | 1 | 2008 | 653 | 0.060 |
Why?
|
| Evoked Potentials | 2 | 2002 | 1031 | 0.060 |
Why?
|
| Exhibitionism | 1 | 1983 | 1 | 0.060 |
Why?
|
| Marijuana Abuse | 1 | 2008 | 411 | 0.060 |
Why?
|
| Hormones | 1 | 2007 | 867 | 0.060 |
Why?
|
| Ethology | 1 | 1983 | 7 | 0.060 |
Why?
|
| Synapses | 1 | 2013 | 1753 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2008 | 643 | 0.050 |
Why?
|
| History, 19th Century | 1 | 2006 | 720 | 0.050 |
Why?
|
| Long-Term Potentiation | 1 | 2005 | 293 | 0.050 |
Why?
|
| Heterosexuality | 1 | 2005 | 294 | 0.050 |
Why?
|
| Menstrual Cycle | 1 | 2006 | 536 | 0.050 |
Why?
|
| Compulsive Personality Disorder | 2 | 2015 | 48 | 0.050 |
Why?
|
| Emigration and Immigration | 1 | 2006 | 395 | 0.050 |
Why?
|
| Noise | 2 | 2020 | 280 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 1997 | 3159 | 0.050 |
Why?
|
| Estradiol | 1 | 2010 | 1932 | 0.050 |
Why?
|
| Narcotics | 1 | 2005 | 336 | 0.050 |
Why?
|
| Sex Factors | 4 | 2010 | 10530 | 0.050 |
Why?
|
| Prospective Studies | 9 | 2020 | 54263 | 0.050 |
Why?
|
| Emergency Medical Services | 2 | 2005 | 1927 | 0.050 |
Why?
|
| Syndrome | 1 | 2009 | 3278 | 0.050 |
Why?
|
| Self-Assessment | 1 | 2004 | 393 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2005 | 900 | 0.050 |
Why?
|
| Adult Children | 1 | 2002 | 103 | 0.050 |
Why?
|
| Territoriality | 1 | 1981 | 6 | 0.050 |
Why?
|
| Affect | 2 | 2004 | 1479 | 0.050 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2006 | 832 | 0.050 |
Why?
|
| Motivation | 2 | 2008 | 1990 | 0.050 |
Why?
|
| Neurotic Disorders | 1 | 1981 | 77 | 0.050 |
Why?
|
| England | 3 | 2009 | 526 | 0.050 |
Why?
|
| Sex Characteristics | 2 | 2013 | 2627 | 0.050 |
Why?
|
| Leukopoiesis | 1 | 2020 | 55 | 0.050 |
Why?
|
| Compulsive Behavior | 2 | 1993 | 117 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2017 | 3524 | 0.050 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2000 | 81 | 0.040 |
Why?
|
| Age Factors | 4 | 2015 | 18415 | 0.040 |
Why?
|
| Rwanda | 1 | 2003 | 662 | 0.040 |
Why?
|
| Environmental Exposure | 2 | 2020 | 4404 | 0.040 |
Why?
|
| Commitment of Mentally Ill | 1 | 1980 | 93 | 0.040 |
Why?
|
| Observer Variation | 1 | 2006 | 2596 | 0.040 |
Why?
|
| Guilt | 1 | 2000 | 96 | 0.040 |
Why?
|
| Smoking | 2 | 2014 | 9070 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2009 | 1905 | 0.040 |
Why?
|
| Psychoses, Substance-Induced | 1 | 1980 | 99 | 0.040 |
Why?
|
| Oxygen Radioisotopes | 1 | 1999 | 75 | 0.040 |
Why?
|
| Prognosis | 4 | 2023 | 29636 | 0.040 |
Why?
|
| Injury Severity Score | 1 | 2003 | 1035 | 0.040 |
Why?
|
| Color Perception | 1 | 2000 | 212 | 0.040 |
Why?
|
| Crime | 1 | 2020 | 202 | 0.040 |
Why?
|
| Emergency Treatment | 1 | 2003 | 498 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2011 | 2163 | 0.040 |
Why?
|
| Forensic Psychiatry | 1 | 1980 | 195 | 0.040 |
Why?
|
| Research | 1 | 2007 | 1973 | 0.040 |
Why?
|
| Predictive Value of Tests | 4 | 2018 | 15273 | 0.040 |
Why?
|
| Prevalence | 5 | 2020 | 15687 | 0.040 |
Why?
|
| Parietal Lobe | 1 | 2004 | 850 | 0.040 |
Why?
|
| Sex Offenses | 1 | 2003 | 351 | 0.040 |
Why?
|
| Models, Psychological | 3 | 2008 | 826 | 0.040 |
Why?
|
| Aptitude Tests | 1 | 1998 | 20 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2002 | 12156 | 0.040 |
Why?
|
| Whole Body Imaging | 1 | 2020 | 278 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2008 | 2143 | 0.040 |
Why?
|
| Accidents, Home | 1 | 1998 | 71 | 0.040 |
Why?
|
| Major Histocompatibility Complex | 1 | 2001 | 928 | 0.040 |
Why?
|
| Ambulatory Care | 2 | 2006 | 2783 | 0.040 |
Why?
|
| Globus Pallidus | 1 | 1999 | 249 | 0.040 |
Why?
|
| Antigens, CD1 | 1 | 2000 | 439 | 0.040 |
Why?
|
| Immunity, Mucosal | 1 | 2001 | 481 | 0.040 |
Why?
|
| Linear Models | 2 | 1998 | 5876 | 0.040 |
Why?
|
| Muscle Contraction | 2 | 1993 | 1201 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2008 | 20048 | 0.040 |
Why?
|
| Photic Stimulation | 4 | 2007 | 1968 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 3466 | 0.040 |
Why?
|
| Glucose | 1 | 2009 | 4361 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2023 | 11141 | 0.040 |
Why?
|
| Trauma Centers | 1 | 2003 | 934 | 0.040 |
Why?
|
| Sympathetic Nervous System | 1 | 2000 | 519 | 0.040 |
Why?
|
| Emergency Service, Hospital | 4 | 2002 | 7809 | 0.040 |
Why?
|
| Inflammation | 1 | 2017 | 10757 | 0.040 |
Why?
|
| Ethanol | 1 | 2023 | 1323 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 2004 | 1500 | 0.030 |
Why?
|
| Semantics | 1 | 2000 | 599 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 10340 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2009 | 3451 | 0.030 |
Why?
|
| Massachusetts | 2 | 2006 | 8805 | 0.030 |
Why?
|
| Vasculitis | 1 | 2020 | 523 | 0.030 |
Why?
|
| Sadism | 1 | 1975 | 6 | 0.030 |
Why?
|
| Psychopathology | 2 | 1990 | 427 | 0.030 |
Why?
|
| Psychological Theory | 1 | 1996 | 176 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 582 | 0.030 |
Why?
|
| Freudian Theory | 1 | 1975 | 32 | 0.030 |
Why?
|
| Gorilla gorilla | 1 | 1995 | 29 | 0.030 |
Why?
|
| Spumavirus | 1 | 1995 | 17 | 0.030 |
Why?
|
| Form Perception | 1 | 1996 | 175 | 0.030 |
Why?
|
| Sexual Behavior | 2 | 1975 | 2080 | 0.030 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 1995 | 69 | 0.030 |
Why?
|
| Counseling | 1 | 2003 | 1550 | 0.030 |
Why?
|
| Terrorism | 2 | 2007 | 211 | 0.030 |
Why?
|
| Substance-Related Disorders | 3 | 2004 | 4370 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2001 | 1354 | 0.030 |
Why?
|
| Air Pollutants | 1 | 2008 | 2843 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 1999 | 1145 | 0.030 |
Why?
|
| Psychiatry | 1 | 1987 | 1686 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2000 | 2852 | 0.030 |
Why?
|
| Recurrence | 3 | 1998 | 8487 | 0.030 |
Why?
|
| Psychological Techniques | 1 | 2014 | 47 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 1981 | 1430 | 0.030 |
Why?
|
| Hostility | 1 | 1994 | 183 | 0.030 |
Why?
|
| United States Department of Defense | 1 | 2013 | 34 | 0.030 |
Why?
|
| Politics | 1 | 1980 | 815 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2000 | 2646 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2001 | 21065 | 0.030 |
Why?
|
| Infant | 5 | 2009 | 36030 | 0.030 |
Why?
|
| Rage | 1 | 1993 | 30 | 0.030 |
Why?
|
| Lie Detection | 1 | 1993 | 8 | 0.030 |
Why?
|
| Irritable Mood | 1 | 1994 | 194 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 783 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 58947 | 0.030 |
Why?
|
| Microdissection | 1 | 2013 | 151 | 0.030 |
Why?
|
| Health Surveys | 1 | 2003 | 4061 | 0.030 |
Why?
|
| Treatment Outcome | 6 | 2018 | 64947 | 0.030 |
Why?
|
| Tropanes | 1 | 2012 | 51 | 0.030 |
Why?
|
| Brain Damage, Chronic | 1 | 2013 | 267 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2024 | 3822 | 0.030 |
Why?
|
| Organotechnetium Compounds | 1 | 2012 | 129 | 0.030 |
Why?
|
| Malingering | 1 | 1993 | 75 | 0.030 |
Why?
|
| Dyskinesia, Drug-Induced | 2 | 1983 | 165 | 0.030 |
Why?
|
| Self Report | 2 | 2014 | 3707 | 0.030 |
Why?
|
| Diazepam | 2 | 1983 | 215 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 290 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2013 | 8551 | 0.020 |
Why?
|
| Thalamic Nuclei | 1 | 1992 | 111 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 1993 | 471 | 0.020 |
Why?
|
| Income | 1 | 2020 | 1876 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 3526 | 0.020 |
Why?
|
| Public Health | 1 | 2005 | 2655 | 0.020 |
Why?
|
| Military Medicine | 1 | 2013 | 187 | 0.020 |
Why?
|
| Antipsychotic Agents | 3 | 1982 | 3061 | 0.020 |
Why?
|
| Government Programs | 1 | 2013 | 280 | 0.020 |
Why?
|
| Panic | 1 | 1991 | 103 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2001 | 2058 | 0.020 |
Why?
|
| Electric Stimulation | 2 | 2006 | 1735 | 0.020 |
Why?
|
| Personality Tests | 1 | 1990 | 81 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 1996 | 2061 | 0.020 |
Why?
|
| Mass Screening | 1 | 2006 | 5422 | 0.020 |
Why?
|
| Interviews as Topic | 2 | 2007 | 2656 | 0.020 |
Why?
|
| Asthma | 1 | 2008 | 6167 | 0.020 |
Why?
|
| Blast Injuries | 1 | 2013 | 322 | 0.020 |
Why?
|
| Pregnancy | 2 | 2022 | 29725 | 0.020 |
Why?
|
| Manuals as Topic | 1 | 1989 | 99 | 0.020 |
Why?
|
| Time Perception | 1 | 1990 | 87 | 0.020 |
Why?
|
| Receptors, Adrenergic | 1 | 1989 | 155 | 0.020 |
Why?
|
| Schizophrenia | 5 | 2015 | 6915 | 0.020 |
Why?
|
| Stereotyped Behavior | 1 | 1989 | 135 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 1799 | 0.020 |
Why?
|
| Task Performance and Analysis | 2 | 2007 | 759 | 0.020 |
Why?
|
| Cluster Analysis | 2 | 2009 | 2698 | 0.020 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2008 | 144 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2020 | 24086 | 0.020 |
Why?
|
| Aging | 1 | 2008 | 8641 | 0.020 |
Why?
|
| Nitrogen Oxides | 1 | 2008 | 128 | 0.020 |
Why?
|
| Videotape Recording | 1 | 1990 | 337 | 0.020 |
Why?
|
| Bipolar Disorder | 1 | 2006 | 5077 | 0.020 |
Why?
|
| Habits | 1 | 1989 | 146 | 0.020 |
Why?
|
| Visual Cortex | 1 | 1996 | 1089 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 1 | 2009 | 260 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2013 | 1181 | 0.020 |
Why?
|
| Pituitary-Adrenal Function Tests | 1 | 2007 | 31 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2013 | 1723 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 1975 | 0.020 |
Why?
|
| Electrochemistry | 1 | 2007 | 143 | 0.020 |
Why?
|
| Educational Status | 1 | 2015 | 2512 | 0.020 |
Why?
|
| Exercise | 1 | 2024 | 5783 | 0.020 |
Why?
|
| Phylogeny | 1 | 1995 | 2775 | 0.020 |
Why?
|
| Twin Studies as Topic | 1 | 2007 | 104 | 0.020 |
Why?
|
| Polysomnography | 1 | 2014 | 1817 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 1346 | 0.020 |
Why?
|
| Individuality | 1 | 2008 | 300 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2018 | 4560 | 0.020 |
Why?
|
| Mass Chest X-Ray | 1 | 2006 | 18 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2007 | 284 | 0.020 |
Why?
|
| Meditation | 1 | 2009 | 251 | 0.020 |
Why?
|
| Basal Ganglia | 1 | 1989 | 552 | 0.020 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2007 | 361 | 0.020 |
Why?
|
| Psychotherapy, Group | 1 | 2009 | 410 | 0.020 |
Why?
|
| Placebos | 1 | 1990 | 1672 | 0.020 |
Why?
|
| Sirolimus | 1 | 2013 | 1548 | 0.020 |
Why?
|
| Yoga | 1 | 2009 | 281 | 0.020 |
Why?
|
| Random Allocation | 1 | 1990 | 2394 | 0.020 |
Why?
|
| France | 1 | 1987 | 511 | 0.020 |
Why?
|
| Impulsive Behavior | 1 | 1988 | 346 | 0.020 |
Why?
|
| Wounds, Gunshot | 1 | 1991 | 581 | 0.020 |
Why?
|
| Tuberculin Test | 1 | 2006 | 206 | 0.020 |
Why?
|
| Fixation, Ocular | 1 | 1987 | 240 | 0.020 |
Why?
|
| Mobile Health Units | 1 | 2006 | 90 | 0.020 |
Why?
|
| Dopamine | 1 | 2012 | 1583 | 0.020 |
Why?
|
| Extraterrestrial Environment | 1 | 2004 | 25 | 0.010 |
Why?
|
| Creatinine | 1 | 1990 | 1906 | 0.010 |
Why?
|
| Outpatients | 1 | 2012 | 1606 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 1344 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 1549 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 2058 | 0.010 |
Why?
|
| Consummatory Behavior | 1 | 1983 | 6 | 0.010 |
Why?
|
| Happiness | 1 | 2005 | 170 | 0.010 |
Why?
|
| Parahippocampal Gyrus | 1 | 2004 | 115 | 0.010 |
Why?
|
| Appetitive Behavior | 1 | 1983 | 39 | 0.010 |
Why?
|
| Mass Media | 1 | 2006 | 300 | 0.010 |
Why?
|
| Testosterone | 1 | 2013 | 2469 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2005 | 1628 | 0.010 |
Why?
|
| Saimiri | 1 | 1983 | 334 | 0.010 |
Why?
|
| London | 1 | 2002 | 234 | 0.010 |
Why?
|
| Escape Reaction | 1 | 1981 | 57 | 0.010 |
Why?
|
| Species Specificity | 1 | 2006 | 2413 | 0.010 |
Why?
|
| Pulse | 1 | 1981 | 218 | 0.010 |
Why?
|
| Efficiency, Organizational | 1 | 2006 | 697 | 0.010 |
Why?
|
| Wales | 1 | 2001 | 86 | 0.010 |
Why?
|
| Choice Behavior | 1 | 2007 | 817 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2008 | 1928 | 0.010 |
Why?
|
| Receptors, KIR | 1 | 2001 | 113 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2009 | 2777 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 20484 | 0.010 |
Why?
|
| Genes, MHC Class I | 1 | 2001 | 240 | 0.010 |
Why?
|
| Anthropometry | 1 | 2005 | 1348 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 2001 | 328 | 0.010 |
Why?
|
| Coercion | 1 | 1980 | 69 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 4409 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2001 | 375 | 0.010 |
Why?
|
| Infant, Newborn | 3 | 2009 | 26168 | 0.010 |
Why?
|
| Acute Disease | 1 | 1991 | 7268 | 0.010 |
Why?
|
| Pain Measurement | 1 | 1990 | 3514 | 0.010 |
Why?
|
| Antigens, CD1d | 1 | 2000 | 217 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1987 | 1534 | 0.010 |
Why?
|
| Neurology | 1 | 2007 | 779 | 0.010 |
Why?
|
| Europe | 1 | 2006 | 3433 | 0.010 |
Why?
|
| Health Status | 1 | 2012 | 4081 | 0.010 |
Why?
|
| Atrophy | 1 | 2004 | 1625 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2009 | 1915 | 0.010 |
Why?
|
| Logistic Models | 1 | 2013 | 13311 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2000 | 2186 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2013 | 8018 | 0.010 |
Why?
|
| Human Rights | 1 | 1980 | 306 | 0.010 |
Why?
|
| Markov Chains | 1 | 2001 | 971 | 0.010 |
Why?
|
| Particulate Matter | 1 | 2008 | 2558 | 0.010 |
Why?
|
| Data Collection | 1 | 2006 | 3317 | 0.010 |
Why?
|
| Visual Fields | 1 | 1983 | 1054 | 0.010 |
Why?
|
| Obesity | 1 | 2018 | 12915 | 0.010 |
Why?
|
| HLA Antigens | 1 | 2001 | 1369 | 0.010 |
Why?
|
| Occupational Diseases | 1 | 2004 | 1484 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 2001 | 1256 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1995 | 195 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2001 | 1434 | 0.010 |
Why?
|
| Immune Sera | 1 | 1995 | 613 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 7400 | 0.010 |
Why?
|
| Proviruses | 1 | 1995 | 313 | 0.010 |
Why?
|
| Patient Admission | 1 | 2001 | 1384 | 0.010 |
Why?
|
| MMPI | 1 | 1993 | 80 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1995 | 729 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 6131 | 0.010 |
Why?
|
| Brain Diseases | 1 | 1982 | 1540 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2000 | 1977 | 0.010 |
Why?
|
| Primates | 1 | 1995 | 523 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2001 | 2536 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2001 | 2204 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1995 | 23363 | 0.010 |
Why?
|
| Cricetinae | 1 | 1995 | 2427 | 0.010 |
Why?
|
| Erectile Dysfunction | 1 | 1974 | 452 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1995 | 2178 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2001 | 3731 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2000 | 3023 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2001 | 3665 | 0.010 |
Why?
|
| Poverty | 1 | 2001 | 2695 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1995 | 1755 | 0.000 |
Why?
|
| Risk | 1 | 2001 | 9629 | 0.000 |
Why?
|
| Speech Perception | 1 | 1993 | 505 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1995 | 2195 | 0.000 |
Why?
|
| Research Design | 1 | 2003 | 6181 | 0.000 |
Why?
|
| Models, Statistical | 1 | 2001 | 5073 | 0.000 |
Why?
|
| Sequence Analysis, DNA | 1 | 1995 | 4717 | 0.000 |
Why?
|
| Base Sequence | 1 | 1995 | 12447 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 2001 | 10183 | 0.000 |
Why?
|
| Phenotype | 1 | 1981 | 16543 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 17628 | 0.000 |
Why?
|
| Cell Line | 1 | 1995 | 15626 | 0.000 |
Why?
|
| Receptors, GABA-A | 1 | 1983 | 621 | 0.000 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1982 | 623 | 0.000 |
Why?
|
| Mood Disorders | 1 | 1982 | 1123 | 0.000 |
Why?
|
| Receptors, Cell Surface | 1 | 1983 | 2825 | 0.000 |
Why?
|